Literature DB >> 2307222

White-cell counts in childhood acute lymphoblastic leukemia.

K Schmiegelow1, M K Pulczynska.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2307222     DOI: 10.1111/j.1600-0609.1990.tb00351.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  3 in total

1.  Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia.

Authors:  Morten Tulstrup; Takaya Moriyama; Chuang Jiang; Marie Grosjean; Jacob Nersting; Jonas Abrahamsson; Kathrine Grell; Lisa Lyngsie Hjalgrim; Ólafur Gísli Jónsson; Jukka Kanerva; Bendik Lund; Stine Nygaard Nielsen; Rikke Linnemann Nielsen; Ulrik Overgaard; Petter Quist-Paulsen; Kaie Pruunsild; Goda Vaitkeviciene; Benjamin Ole Wolthers; Hui Zhang; Ramneek Gupta; Jun J Yang; Kjeld Schmiegelow
Journal:  Blood       Date:  2020-09-03       Impact factor: 22.113

2.  Methotrexate and 6-mercaptopurine maintenance therapy for childhood acute lymphoblastic leukemia: dose adjustments by white cell counts or by pharmacokinetic parameters?

Authors:  K Schmiegelow; H Schrøder; M Schmiegelow
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 3.  Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.

Authors:  Kjeld Schmiegelow; Stine N Nielsen; Thomas L Frandsen; Jacob Nersting
Journal:  J Pediatr Hematol Oncol       Date:  2014-10       Impact factor: 1.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.